Artwork

内容由Skeptics in the Pub Online提供。所有播客内容(包括剧集、图形和播客描述)均由 Skeptics in the Pub Online 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal
Player FM -播客应用
使用Player FM应用程序离线!

Ivermectin for COVID-19: A Tale of Science Gone Wrong? – Jack Lawrence

1:07:26
 
分享
 

Manage episode 355161029 series 3327627
内容由Skeptics in the Pub Online提供。所有播客内容(包括剧集、图形和播客描述)均由 Skeptics in the Pub Online 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

The COVID-19 pandemic has spurred a host of scientific triumphs but also numerous failures and declining reputations. One such example is the antiparasitic medication ivermectin, which had previously gained a reputation as a highly effective "wonder drug" but has since faced much controversy during the pandemic. Initially hailed as a potential miracle cure for COVID-19, further examination revealed that ivermectin had little effect on the disease.

Jack Lawrence, played an instrumental role in uncovering signs of research misconduct in several high-profile ivermectin for COVID-19 studies after stumbling upon fabricated data in a major ivermectin study during a university assignment. Following his discovery, Jack teamed up with a group of scientific data sleuths to examine further ivermectin studies. In his talk, Jack will outline the history of ivermectin and the lessons we can draw from its rise and fall as a potential COVID-19 cure. He will also take us behind the scenes of his journey into the world of scientific fraud and how he spotted what passed the notice of many.

Jack Lawrence obtained a Master’s degree from St George’s, University of London in July 2022. His research was focused on improving pancreatic cancer treatment options. He currently works on projects to improve research integrity and transparency. During the COVID-19 pandemic Jack discovered scientific misconduct and fraud in several influential papers purporting to show strong benefits for using ivermectin to treat COVID-19.

The music used in this episode is by Thula Borah and is used with permission.

  continue reading

71集单集

Artwork
icon分享
 
Manage episode 355161029 series 3327627
内容由Skeptics in the Pub Online提供。所有播客内容(包括剧集、图形和播客描述)均由 Skeptics in the Pub Online 或其播客平台合作伙伴直接上传和提供。如果您认为有人在未经您许可的情况下使用您的受版权保护的作品,您可以按照此处概述的流程进行操作https://zh.player.fm/legal

The COVID-19 pandemic has spurred a host of scientific triumphs but also numerous failures and declining reputations. One such example is the antiparasitic medication ivermectin, which had previously gained a reputation as a highly effective "wonder drug" but has since faced much controversy during the pandemic. Initially hailed as a potential miracle cure for COVID-19, further examination revealed that ivermectin had little effect on the disease.

Jack Lawrence, played an instrumental role in uncovering signs of research misconduct in several high-profile ivermectin for COVID-19 studies after stumbling upon fabricated data in a major ivermectin study during a university assignment. Following his discovery, Jack teamed up with a group of scientific data sleuths to examine further ivermectin studies. In his talk, Jack will outline the history of ivermectin and the lessons we can draw from its rise and fall as a potential COVID-19 cure. He will also take us behind the scenes of his journey into the world of scientific fraud and how he spotted what passed the notice of many.

Jack Lawrence obtained a Master’s degree from St George’s, University of London in July 2022. His research was focused on improving pancreatic cancer treatment options. He currently works on projects to improve research integrity and transparency. During the COVID-19 pandemic Jack discovered scientific misconduct and fraud in several influential papers purporting to show strong benefits for using ivermectin to treat COVID-19.

The music used in this episode is by Thula Borah and is used with permission.

  continue reading

71集单集

所有剧集

×
 
Loading …

欢迎使用Player FM

Player FM正在网上搜索高质量的播客,以便您现在享受。它是最好的播客应用程序,适用于安卓、iPhone和网络。注册以跨设备同步订阅。

 

快速参考指南